ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,020.14
-0.31%
Dow Jones
37,908.46
0.24%
US Dollar vs MXN
17.03845
-0.67%
Brent Oil
84.205
-1.97%
Bitcoin
57,037.80
-5.88%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Seelos Therapeutics Inc (SEEL)

  7. Seelos Therapeutics Inc (SEEL) Noticias

SEEL Seelos Therapeutics Inc

0.2808
0.0018 (0.65%)
Última actualización: 10:11:45
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Seelos Therapeutics Inc SEEL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.0018 0.65% 0.2808 10:11:45
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.2932 0.272 0.30 0.279
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/3/202416:32EDGAR2Form S-1/A - General form for registration of securities..
06/3/202415:50EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:50EDGAR2Form D - Notice of Exempt Offering of Securities
06/2/202416:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/2/202405:04EDGAR2Form S-1 - General form for registration of securities under..
30/1/202415:01EDGAR2Form 8-K - Current report
30/1/202405:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/1/202407:05EDGAR2Form 8-K - Current report
17/1/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:16EDGAR2Form 8-K - Current report
08/1/202420:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202420:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202420:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202420:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202407:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202315:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202307:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/12/202315:59EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/12/202315:54EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/12/202315:54EDGAR2Form S-3 - Registration statement under Securities Act of..
15/12/202315:06EDGAR2Form DEF 14A - Other definitive proxy statements
04/12/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
01/12/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:08EDGAR2Form 8-K - Current report
30/11/202315:59EDGAR2Form 8-K - Current report
30/11/202315:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202315:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202315:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/11/202308:00EDGAR2Form 8-K - Current report
24/11/202311:07EDGAR2Form 8-K - Current report
24/11/202310:10EDGAR2Form 8-K - Current report
03/11/202315:15EDGAR2Form 8-K - Current report
02/10/202305:03EDGAR2Form 8-K - Current report
29/9/202315:56EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/9/202315:06EDGAR2Form 8-K - Current report
25/9/202305:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/9/202306:00EDGAR2Form 8-K - Current report
15/9/202315:01EDGAR2Form S-3 - Registration statement under Securities Act of..
14/9/202308:00EDGAR2Form 8-K - Current report
01/9/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/6/202308:00EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
SEEL
Seelos Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados